Here the authors develop a ferritin-based protein nanoparticle vaccine candidate for SARS-CoV-2, and show induction of neutralizing antibodies to variants of concern, including Omicron BQ.1, in non-human primates after initial immunization and a booster dose.
- Payton A.-B. Weidenbacher
- Mrinmoy Sanyal
- Peter S. Kim
